ALDX
Price
$5.17
Change
-$0.27 (-4.96%)
Updated
Jul 25 closing price
Capitalization
309.66M
13 days until earnings call
CLLS
Price
$2.52
Change
+$0.52 (+26.00%)
Updated
Jul 25 closing price
Capitalization
224.18M
5 days until earnings call
Interact to see
Advertisement

ALDX vs CLLS

Header iconALDX vs CLLS Comparison
Open Charts ALDX vs CLLSBanner chart's image
Aldeyra Therapeutics
Price$5.17
Change-$0.27 (-4.96%)
Volume$1.76M
Capitalization309.66M
Cellectis SA
Price$2.52
Change+$0.52 (+26.00%)
Volume$954.83K
Capitalization224.18M
ALDX vs CLLS Comparison Chart in %
Loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALDX vs. CLLS commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALDX is a Hold and CLLS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (ALDX: $5.17 vs. CLLS: $2.52)
Brand notoriety: ALDX and CLLS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALDX: 163% vs. CLLS: 742%
Market capitalization -- ALDX: $309.66M vs. CLLS: $224.18M
ALDX [@Biotechnology] is valued at $309.66M. CLLS’s [@Biotechnology] market capitalization is $224.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALDX’s FA Score shows that 0 FA rating(s) are green whileCLLS’s FA Score has 1 green FA rating(s).

  • ALDX’s FA Score: 0 green, 5 red.
  • CLLS’s FA Score: 1 green, 4 red.
According to our system of comparison, both ALDX and CLLS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALDX’s TA Score shows that 2 TA indicator(s) are bullish while CLLS’s TA Score has 6 bullish TA indicator(s).

  • ALDX’s TA Score: 2 bullish, 4 bearish.
  • CLLS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, CLLS is a better buy in the short-term than ALDX.

Price Growth

ALDX (@Biotechnology) experienced а -4.08% price change this week, while CLLS (@Biotechnology) price change was +38.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

ALDX is expected to report earnings on Nov 13, 2025.

CLLS is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALDX($310M) has a higher market cap than CLLS($224M). CLLS YTD gains are higher at: 40.000 vs. ALDX (3.607). CLLS has higher annual earnings (EBITDA): -32.49M vs. ALDX (-55.54M). CLLS has more cash in the bank: 242M vs. ALDX (90.1M). ALDX has less debt than CLLS: ALDX (15.6M) vs CLLS (91.8M). CLLS has higher revenues than ALDX: CLLS (47.6M) vs ALDX (0).
ALDXCLLSALDX / CLLS
Capitalization310M224M138%
EBITDA-55.54M-32.49M171%
Gain YTD3.60740.0009%
P/E RatioN/AN/A-
Revenue047.6M-
Total Cash90.1M242M37%
Total Debt15.6M91.8M17%
FUNDAMENTALS RATINGS
ALDX vs CLLS: Fundamental Ratings
ALDX
CLLS
OUTLOOK RATING
1..100
8227
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
29
Undervalued
PROFIT vs RISK RATING
1..100
91100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
3640
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLLS's Valuation (29) in the Biotechnology industry is in the same range as ALDX (47). This means that CLLS’s stock grew similarly to ALDX’s over the last 12 months.

ALDX's Profit vs Risk Rating (91) in the Biotechnology industry is in the same range as CLLS (100). This means that ALDX’s stock grew similarly to CLLS’s over the last 12 months.

ALDX's SMR Rating (97) in the Biotechnology industry is in the same range as CLLS (97). This means that ALDX’s stock grew similarly to CLLS’s over the last 12 months.

ALDX's Price Growth Rating (36) in the Biotechnology industry is in the same range as CLLS (40). This means that ALDX’s stock grew similarly to CLLS’s over the last 12 months.

ALDX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CLLS (100). This means that ALDX’s stock grew similarly to CLLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALDXCLLS
RSI
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
77%
MACD
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
68%
Advances
ODDS (%)
Bullish Trend 16 days ago
83%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 10 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
59%
View a ticker or compare two or three
Interact to see
Advertisement
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EGHSF17.350.10
+0.57%
Enghouse Systems Ltd.
CRTD0.32N/A
N/A
CREATD INC.
CIIHF3.03N/A
N/A
Citic Securities Co., Ltd.
TIAOF0.47N/A
N/A
Telecom Italia S.p.A.
AMYZF0.05N/A
-0.20%
RECYCLICO BATTERY MATERIALS INC.

ALDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with CANF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then CANF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALDX
1D Price
Change %
ALDX100%
-4.96%
CANF - ALDX
46%
Loosely correlated
-2.97%
CMVLF - ALDX
39%
Loosely correlated
N/A
CLLS - ALDX
39%
Loosely correlated
+26.00%
CGON - ALDX
39%
Loosely correlated
-0.15%
PLRX - ALDX
38%
Loosely correlated
-1.26%
More

CLLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLLS has been closely correlated with CMVLF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if CLLS jumps, then CMVLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLLS
1D Price
Change %
CLLS100%
+26.00%
CMVLF - CLLS
82%
Closely correlated
N/A
ABCZF - CLLS
58%
Loosely correlated
N/A
SLN - CLLS
43%
Loosely correlated
+0.96%
MDGL - CLLS
40%
Loosely correlated
-0.26%
PMVP - CLLS
38%
Loosely correlated
-2.08%
More